News
04-26-2024, 03:50 AM
The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer.
More... (https://www.news-medical.net/news/20240426/First-UK-real-world-study-shows-promise-for-sacituzumab-govitecan-in-metastatic-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20240426/First-UK-real-world-study-shows-promise-for-sacituzumab-govitecan-in-metastatic-breast-cancer.aspx)